Enhance your nephrology practice with CME and tools focused on kidney medicine.
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Kelly Chenlei Li, MBBS, FRACP
Paul Bennett, RN, MHSM, PhD, FISN
Thilo Krüger, MD, PhD
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Jurgen Floege MD
Uyen Huynh-Do, MD
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, DMSc, MD
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD, FASN
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
Jay Reddy, MD, FASN
Carlos Narváez Mejía, MD
Understanding the Recent Advances in IgAN
Jürgen Floege, MD
Jonathan Barratt, PhD
Why We Should Be PRO Patients With CKD-Associated Pruritus
Lucio Manenti, MD, PhD
Jeanette Finderup, PhD, MHR, RN
Sebastian Koball, MD
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
Joel Topf, MD
James Burton, MD
Curbside Consult: Optimizing IgAN Management
Khalil El Karoui, MD
Federico Alberici, MD, PhD
I Just Need to Sleep! Improving Itch in Patients With CKD-aP
Kieran McCafferty, MD
Prof. Dr. Jörg Latus
Call to Action: Elevating CKD-aP Care
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George L. Bakris, MD, FAHA, FASN
David Bushinsky, MD
Lars Lund, MD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
C5a Receptor Inhibition With Avacopan: A Novel Treatment Approach for ANCA-Associated Vasculitis
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
The CKD Patient: Thinking Beyond the Numbers and Dialysis
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Steven Fishbane, MD
Separating Fact from Fiction: The Realities of CKD-aP
Antoine Lanot, MD, PhD
Case-Based Management of AAV
Annette Bruchfeld, MD, PhD
Updates in Glomerular Disease
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.